Medifast, Inc. (MED)

NYSE: MED · Real-Time Price · USD
12.45
-0.03 (-0.24%)
May 18, 2026, 4:00 PM EDT - Market closed
Market Cap127.65M -10.5%
Revenue (ttm)346.10M -36.3%
Net Income-20.02M
EPS-1.82
Shares Out 10.25M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume173,932
Open12.65
Previous Close12.48
Day's Range12.39 - 12.81
52-Week Range9.22 - 15.46
Beta0.57
AnalystsHold
Price Target12.00 (-3.61%)
Earnings DateMay 4, 2026

About MED

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND,... [Read more]

Founded 1980
Employees 380
Stock Exchange NYSE
Ticker Symbol MED
Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to one analyst, the rating for MED stock is "Hold" and the 12-month stock price target is $12.0.

Price Target
$12.0
(-3.61% downside)
Analyst Consensus: Hold
Stock Forecasts

News

Peer-Reviewed Research Is Redefining Weight Loss Program Standards

The global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across the category Randomized controlled trials control f...

3 days ago - GlobeNewsWire

Peer-Reviewed Research Shows Structured Meal Replacement Programs Support Visceral Fat Reduction and Lean Mass Preservation

Body composition, specifically visceral fat levels and lean mass, plays a meaningful role in long-term metabolic health (Serra MC, et al., 2019) Structured plans, habit building, and dedicated coach s...

3 days ago - GlobeNewsWire

Medifast Earnings Call Transcript: Q1 2026

Sequential revenue growth returned for the first time in three years, driven by a 19% year-over-year increase in coach productivity and strong referral activity, despite a 34% revenue decline and ongoing disruption from GLP-1 medications. Profitability improvements are targeted for Q4 2026, with a new product launch and cost savings expected to support future growth.

14 days ago - Transcripts

Medifast Earnings release: Q1 2026

Medifast released its Q1 2026 earnings on May 4, 2026, summarizing the period's financial results.

14 days ago - Filings

Medifast Slides: Q1 2026

Medifast has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 4, 2026.

14 days ago - Filings

Medifast Quarterly report: Q1 2026

Medifast has published its Q1 2026 quarterly earnings report on May 4, 2026.

14 days ago - Filings

Medifast sees Q2 EPS ($1.00)-(50c), one estimate (43c)

Sees Q2 revenue $60M-$80M, one estimate $74.7M

14 days ago - TheFly

Medifast sees FY26 EPS ($2.75)-($1.55), one estimate ($1.98)

Sees FY26 revenue $270M-$300M, one estimate $273.7M

14 days ago - TheFly

Medifast reports Q1 EPS (19c), one estimate (52c)

Reports Q1 revenue $76.0M, one estimate $69.2M. “We are encouraged by the continued progress we are seeing as we execute our metabolic health strategy, including a second consecutive quarter of…

14 days ago - TheFly

Medifast Announces First Quarter 2026 Financial Results

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the first quarter en...

14 days ago - Business Wire

Medifast Proxy statement: Proxy filing

Medifast filed a proxy statement on April 30, 2026, providing details for shareholder voting and corporate governance matters.

18 days ago - Filings

Medifast to Announce Financial Results for the First Quarter Ended March 31, 2026

BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quarter...

4 weeks ago - Business Wire

Medifast Proxy statement: Proxy filing

Medifast filed a proxy statement on April 6, 2026, providing details for shareholder voting and corporate governance matters.

6 weeks ago - Filings

Medifast Proxy statement: Proxy filing

Medifast filed a proxy statement on April 6, 2026, providing details for shareholder voting and corporate governance matters.

6 weeks ago - Filings

Medifast announces cooperation agreement with Steamboat Capital

Medifast (MED) announced the company’s board of directors has agreed to nominate Parsa Kiai and Jeff Rose from Steamboat Capital Partners as independent director candidates to stand for election at…

2 months ago - TheFly

Medifast Announces Cooperation Agreement with Steamboat Capital

BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED), the metabolic health and wellness company known for its science-backed, coach-guided lifestyle system, today announced the company's Board of Di...

2 months ago - Business Wire

Medifast announces Optavia available for HSA, FSA reimbursement

Medifast (MED) announced that Optavia’s metabolic health system is now available for reimbursement on select insurance plans using Health Savings Accounts and Flexible Spending Accounts. “This is a ma...

3 months ago - TheFly

Scientific Evidence Demonstrates OPTAVIA®'s Metabolic Health Benefits, Opening the Door to Qualified HSA/FSA Clients

BALTIMORE--(BUSINESS WIRE)--As part of its continued focus on improving metabolic health, Medifast® (NYSE: MED) today announced that OPTAVIA's comprehensive metabolic health system is available for re...

3 months ago - Business Wire

Medifast price target lowered to $12 from $15 at Stephens

Stephens lowered the firm’s price target on Medifast (MED) to $12 from $15 and keeps an Equal Weight rating on the shares. While the firm believes that operating discipline and…

3 months ago - TheFly

Medifast Earnings Call Transcript: Q4 2025

Q4 2025 saw revenue drop 36.9% year-over-year due to a smaller coach base, but coach productivity rose 6%, marking the first positive trend since 2022. The company is transitioning to a metabolic health focus, expects new product launches in late 2026, and targets profitability improvements starting Q4 2026.

3 months ago - Transcripts

Medifast Annual report: Q4 2025

Medifast has published its Q4 2025 annual report on February 17, 2026.

3 months ago - Filings

Medifast Earnings release: Q4 2025

Medifast released its Q4 2025 earnings on February 17, 2026, summarizing the period's financial results.

3 months ago - Filings

Medifast Slides: Q4 2025

Medifast has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 17, 2026.

3 months ago - Filings

Medifast sees FY26 EPS ($2.75)-($1.55)

Sees FY26 revenue $270M-$300M

3 months ago - TheFly

Medifast reports Q4 EPS ($1.65) vs 7c last year

Reports Q4 revenue $75.1M vs $119.003M last year. “As we enter 2026, Medifast (MED) is moving from defining its business transformation strategy to executing on a new path to growth,…

3 months ago - TheFly